Retatrutide Research Video Explainer

For in-vitro and laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.

This short video explains Retatrutide as a research compound. Retatrutide is GLP-1, GIP & Glucagon Receptor Triple Agonist. It covers its molecular identity (CAS 2381089-83-2, 4731.33 g/mol) and the pathways studied in laboratory models. A second video is included below.

In stock and UK lab tested

Key facts

What Retatrutide is studied for

• Investigating simultaneous activation of human GLP-1R, GIPR & GCGR in metabolic models.
• Comparing multi-receptor incretin + glucagon energy-expenditure signalling vs single agonists.
• Studying hepatic lipid oxidation, glycaemic homeostasis & adipose thermogenesis pathways.

What the video covers

Each slide in the 60-second explainer follows one line of published laboratory work, not a medical outcome.

• 1. Triple Receptor Binding Binds GLP-1R, GIPR and Glucagon (GCGR) G-protein-coupled receptors on target cells.
• 2. Gs / Adenylyl Cyclase Cascade Elevates intracellular cAMP, activating PKA and EPAC2 second-messenger pathways.
• 3. Cellular Metabolic Readout Coordinates insulinotropic signalling, lipolysis & hepatic fatty-acid oxidation in vitro.

Related research videos

• Tirzepatide research video
• Cagrilintide research video
• Semaglutide research video
• All 164 peptide research videos

Batch checks and handling

Every vial carries a report number. Match it to its certificate on the COA verification page before you start work. Lyophilised vials are best kept sealed, dry and at −20 °C or colder, away from light. Reconstitution and storage are covered step by step in our reconstitution and storage guide.

Corex Vitality™ supplies Retatrutide strictly for in-vitro laboratory research by adults aged 18 or over. It is not a medicine, it is not for human or veterinary use, and no information on this page describes use in people or animals. Read the full terms of sale.